-
21.发明公开모시풀 추출물을 유효성분으로 함유하는 콜레스테롤 저감, 체중조절 및 비알코올성 지방간 개선용 건강기능식품 有权功能性食物降低胆固醇水平，体重调节，改善含有BOEHMERIA NIVEA（L.）GAUDICH的非酒精性脂肪肝
公开(公告)号：KR1020140080982A
公开(公告)日：2014-07-01
申请号：KR1020120150241
申请日：2012-12-21
IPC: A23L33/00 , A23L2/38 , A61K36/342
CPC classification number: A23L33/105 , A23L2/38 , A23V2002/00 , A23V2200/332 , A23V2250/21 , A61K36/342 , A61K2236/33
Abstract: The present invention relates to a functional food for lowering cholesterol level, regulating weight, and improving nonalcoholic fatty liver, which contains the extract of Boehmeria nivea (L.) gaudich as an active ingredient. By containing Boehmeria nivea (L.) gaudich as an active ingredient, the function food can absorb blood sugar, decrease adipocytic differentiation, and reduce fatty liver, glucose, and fat content, and also is edible by not having toxicity.
Abstract translation: 本发明涉及含有Boehmeria nivea（L.）gaudich作为活性成分的提取物的降低胆固醇水平，调节重量和改善非酒精性脂肪肝的功能性食品。 通过含有Boehmeria nivea（L.）gaudich作为活性成分，功能食物可以吸收血糖，减少脂肪细胞分化，减少脂肪肝，葡萄糖和脂肪含量，也可通过无毒性食用。
-
公开(公告)号：KR101349083B1
公开(公告)日：2014-01-16
申请号：KR1020120020537
申请日：2012-02-28
Applicant: 한국식품연구원
CPC classification number: Y02A90/26
Abstract: 본 발명은 간 추출물에 존재하는 특정 대사체의 농도를 측정하여 노화 진단을 위한 정보를 제공하는 방법 및 진단용 키트에 관한 것이다. 본 발명에 따르면 간 추출물에 존재하는 특정 대사체의 농도 변화를 측정하여 노화의 진행 여부 및 노화와 관련된 질병을 진단할 수 있고, 나아가 노화와 연관된 질병의 치료에 활용할 수 있다.
-
公开(公告)号：KR1020130078326A
公开(公告)日：2013-07-10
申请号：KR1020110147201
申请日：2011-12-30
Applicant: 한국식품연구원
IPC: A61K31/353 , A61K9/08 , A61P17/00
Abstract: PURPOSE: A pharmaceutical composition containing auraptene as an active ingredient for promoting angiogenesis is provided to promote angiogenesis by auraptene, and to effectively regenerate tissues through skin flap regeneration, wound and burn healing, and artificial skin transplantation. CONSTITUTION: A pharmaceutical composition for promoting angiogenesis contains 1-10 micromole of auraptene as an active ingredient. Auraptene promotes tissue regeneration. The pharmaceutical composition is used for skin flap regeneration, wound and burn healing, artificial skin transplantation, or preparation of blood vessels for transplantation. A food composition for promoting angiogenesis contains auraptene as an active ingredient. Auraptene promotes angiogenesis. [Reference numerals] (AA) Control group; (BB) Auraptene 1μM; (CC) Auraptene 5μM; (DD) Auraptene 10μM; (EE) Auraptene 40μM
Abstract translation: 目的：提供含有紫罗烯作为促进血管发生的活性成分的药物组合物，用于促进紫罗烯烯的血管生成，并通过皮瓣再生，伤口和烧伤愈合以及人造皮肤移植有效地再生组织。 构成：用于促进血管发生的药物组合物含有1-10微摩尔的奥来哌啶作为活性成分。 Auraptene促进组织再生。 药物组合物用于皮瓣再生，伤口和烧伤愈合，人造皮肤移植或用于移植的血管制备。 用于促进血管生成的食品组合物含有作为活性成分的紫罗烯。 Auraptene促进血管生成。 （附图标记）（AA）对照组; （BB）Auraptene1μM; （CC）Auraptene5μM; （DD）Auraptene10μM; （EE）Auraptene40μM
-
公开(公告)号：KR1020130021422A
公开(公告)日：2013-03-05
申请号：KR1020130001241
申请日：2013-01-04
Applicant: 주식회사디엔에이링크 , 한국식품연구원
CPC classification number: C12Q1/6883 , C12N15/11 , C12Q1/6837 , C12Q2600/156
Abstract: PURPOSE: A polynucleotide for diagnosing a risk of developing metabolic syndrome is provided to quickly and effectively diagnose a risk of developing metabolic syndrome of an individual. CONSTITUTION: A polynucleotide for diagnosing a risk of developing metabolic syndrome of an individual with obesity is selected from the group consisting of sequence numbers 2-4, or a complementary polynucleotide thereof. The polynucleotide has 10 or more continuous nucleotides with SNP at 101th base of sequence numbers 2-4.
Abstract translation: 目的：提供用于诊断发生代谢综合征风险的多核苷酸，以快速有效地诊断发生个体代谢综合征的风险。 构成：用于诊断患有肥胖个体的代谢综合征风险的多核苷酸选自序列号2-4或其互补多核苷酸。 该多核苷酸在序列号2-4的第101位具有10个或更多个具有SNP的连续核苷酸。
-
公开(公告)号：KR1020120048205A
公开(公告)日：2012-05-15
申请号：KR1020100109716
申请日：2010-11-05
Applicant: 한국식품연구원
IPC: A61K31/198 , A61P3/04 , A61P3/06 , A61P3/10
Abstract: PURPOSE: A pharmaceutical composition and health food containing methylselenocystein is provided to prevent and treat obesity and lipid-related metabolic diseases. CONSTITUTION: A pharmaceutical composition for preventing and treating obesity and lipid-related metabolic diseases contains methylselenocysteine as an active ingredient. The composition is manufactured in the form of powder, granules, tablets, capsules, suspension, emulsion, syrup, oral formulation of aerosol, external use, suppository, or sterilized injection solution. A health food for preventing and relieving obesity and metabolic diseases contains methylselenocystein as an active ingredient. The health food is manufactured in the form of capsules, tablets, granules, powder, or beverage.
Abstract translation: 目的：提供含有甲基硒代半胱氨酸的药物组合物和保健食品，用于预防和治疗肥胖症和与脂质有关的代谢疾病。 构成：用于预防和治疗肥胖症和脂质相关代谢疾病的药物组合物含有甲基硒代半胱氨酸作为活性成分。 该组合物以粉末，颗粒，片剂，胶囊，悬浮液，乳剂，糖浆，气雾剂口服制剂，外用，栓剂或灭菌注射液的形式制备。 用于预防和缓解肥胖和代谢疾病的保健食品含有甲基硒代半胱氨酸作为活性成分。 保健食品以胶囊，片剂，颗粒，粉末或饮料的形式制造。
-
Patent Agency Ranking
公开(公告)号：KR1020120004828A
公开(公告)日：2012-01-13
申请号：KR1020100065515
申请日：2010-07-07
Applicant: 한국식품연구원
IPC: A61K31/05 , A61K31/045 , A61P29/00
Abstract: PURPOSE: A 2,4 D-tertiary-butylphenol or salt thereof for anti-inflammation is provided to suppress iNOS expression and to prevent and treat inflammation. CONSTITUTION: An anti-inflammatory composition contains 2,4 D-tertiary-butylphenol or salt thereof as an active ingredient. A pharmaceutical composition for preventing and treating inflammation contains 2,4 D-tertiary phenol or pharmacologically acceptable salt thereof as an active ingredient. A food composition for preventing and treating inflammation contains 0.01-10 wt% of 2,4-D-tertiary-butylphenol or sitologically acceptable salt thereof as an active ingredient. The salt is acid addition salt.
Abstract translation: 目的：提供用于抗炎的2,4-二叔丁基苯酚或其盐以抑制iNOS表达并预防和治疗炎症。 构成：抗炎组合物含有2,4-二叔丁基苯酚或其盐作为活性成分。 用于预防和治疗炎症的药物组合物含有2,4-二叔酚或其药理学上可接受的盐作为活性成分。 用于预防和治疗炎症的食品组合物含有0.01-10重量％的2,4-D-叔丁基苯酚或其可以选择的盐作为活性成分。 盐是酸加成盐。
-
-
公开(公告)号：KR101714370B1
公开(公告)日：2017-03-10
申请号：KR1020140159911
申请日：2014-11-17
Applicant: 한국식품연구원
Abstract: 본발명은푸니칼라진(punicalagin)을유효성분으로함유하는전립선비대증의예방또는치료용약학적조성물, 식품조성물및 건강기능식품에관한것으로, 본발명에따른푸니칼라진은전립선무게감소효과가우수하므로, 이를유효성분으로함유하는전립선비대증의예방또는치료용약학적조성물, 식품조성물및 건강기능식품으로사용할수 있다.
Abstract translation: 本发明涉及一种用于预防或治疗良性前列腺增生的药物组合物，其包含作为活性成分的肾上腺素作为食物组合物，以及健康功能性食品。 根据本发明，防腐剂对减轻前列腺的重量具有优异的效果，可以用作预防或治疗良性前列腺增生的药物组合物，其包含与活性成分相同的食品组合物和 健康功能食品。
-
公开(公告)号：KR1020160059029A
公开(公告)日：2016-05-26
申请号：KR1020140159913
申请日：2014-11-17
Applicant: 한국식품연구원
IPC: A61K31/404 , A61P13/08 , A61P13/00
CPC classification number: A61K31/404 , A23L33/00 , A23L33/10 , A61K31/405
Abstract: 본발명은디인돌릴메탄(diindolylmethane)을유효성분으로함유하는전립선비대증의예방또는치료용약학적조성물, 식품조성물및 건강기능식품에관한것으로, 본발명에따른디인돌릴메탄은전립선무게감소효과가우수하므로, 이를유효성분으로함유하는전립선비대증의예방또는치료용약학적조성물, 식품조성물및 건강기능식품으로사용할수 있다.
Abstract translation: 本发明涉及一种用于预防或治疗良性前列腺增生的药物组合物，其包含二吲哚基甲烷作为活性成分，食品组合物和健康功能性食品。 根据本发明，二吲哚基甲烷在降低前列腺重量方面具有优异的效果，可用作预防或治疗良性前列腺增生的药物组合物，食品组合物和保健功能食品，其包括与 活性成分。
-
公开(公告)号：KR1020160008016A
公开(公告)日：2016-01-21
申请号：KR1020140087348
申请日：2014-07-11
Applicant: 한국식품연구원
IPC: A61K31/352 , A61K31/35
CPC classification number: A61K31/352 , A61K31/35
Abstract: 본발명은폴리메톡실플라본(Polymethoxylated flavones; PMFs)을유효성분으로함유하는후각장애예방또는치료용약학조성물에관한것이다. 또한, 본발명은폴리메톡실플라본을유효성분으로함유하는후각장애예방또는개선용건강기능식품에관한것이다. 본발명의폴리메톡실플라본을함유하는조성물은후각자극에의한 cAMP의생성을촉진시켜, 다양한후각자극물질에대해냄새인지를증진시키는역할을한다.
Abstract translation: 本发明涉及一种预防或治疗嗅觉障碍的药物组合物，其包含多甲氧基化黄酮（PMF）作为活性成分。 此外，本发明涉及一种防止或改善嗅觉障碍的健康功能食品，其包含PMF作为活性成分。 根据本发明的包含PMF的组合物通过嗅觉刺激刺激cAMP的产生并增强关于各种嗅觉兴奋剂的嗅觉识别。
-
-
-
-
-
-
-
-
-
Search Results
72
records
(took 0.026 seconds)
